| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9cafc17699713db7172dc81a3749fe1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate |
2004-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_480e8afdc4bd464a18bc8ff6f67d48d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16d1eaedf6a85888386aa51d2000fa8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9ed160f96df7ab17f312af2502328be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28962013bf6ee2277ba00baef10074e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3016fecc876e053fb841f4ef350ea3c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60af091b61adad30f47e1945051489bf |
| publicationDate |
2005-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20050121721-A |
| titleOfInvention |
Improved heat shock protein-based vaccines and immunotherapies |
| abstract |
At least one antigenic c domain, at least one heat shock protein binding domain and between, useful for inducing an immune response against the antigenic domain when administered alone or in combination with at least one heat shock protein. Hybrid antigens comprising at least one improved peptide linker of are described. The hybrid antigens and complexes can be used to treat infectious diseases and tumors that express antigens of their antigenic domains. |
| priorityDate |
2003-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |